Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VVD-130850 by Vividion Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
VVD-130850 is under clinical development by Vividion Therapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
VVD-130850 by Vividion Therapeutics for Solid Tumor: Likelihood of Approval
VVD-130850 is under clinical development by Vividion Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
VVD-130850 by Vividion Therapeutics for Non-Hodgkin Lymphoma: Likelihood of Approval
VVD-130850 is under clinical development by Vividion Therapeutics and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase...